Fortitude Family Office’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50 Buy
+2
New +$47 ﹤0.01% 2207
2025
Q3
Sell
-93
Closed -$1.14K 1997
2025
Q2
$1.14K Buy
+93
New +$1.17K ﹤0.01% 1448
2025
Q1
Sell
-25
Closed -$398 1159
2024
Q4
$398 Hold
25
﹤0.01% 1232
2024
Q3
$601 Sell
25
-6
-19% -$137 ﹤0.01% 1150
2024
Q2
$618 Buy
+31
New +$604 ﹤0.01% 912

Other funds holding AVNS

Fortitude Family Office's AVNS Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Avanos Medical (AVNS) in Q2 2026: 2 shares worth $50. The stake represents ﹤0.01% of the portfolio and ranks #2207 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in AVNS as recently as Q2 2025.

Fortitude Family Office first reported a position in AVNS in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.14K in Q2 2025. 82 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Fortitude Family Office held 2 shares of Avanos Medical worth $50 as of Q2 2026.
  • Avanos Medical was a new Fortitude Family Office position in Q2 2026.
  • Avanos Medical made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2207 holding.
  • Fortitude Family Office first reported a position in Avanos Medical in Q2 2024 and has held it in 5 quarters since.
  • Fortitude Family Office's Avanos Medical position peaked at $1.14K in Q2 2025.
  • 82 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.